MARTORANA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 28.566
EU - Europa 2.091
AS - Asia 1.124
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
AF - Africa 6
Totale 31.826
Nazione #
US - Stati Uniti d'America 28.550
SG - Singapore 627
UA - Ucraina 382
DE - Germania 356
IT - Italia 307
IE - Irlanda 297
CN - Cina 289
RU - Federazione Russa 192
FR - Francia 141
KR - Corea 130
GB - Regno Unito 105
SE - Svezia 89
FI - Finlandia 78
PL - Polonia 65
NL - Olanda 20
BE - Belgio 16
CZ - Repubblica Ceca 16
JP - Giappone 14
KG - Kirghizistan 14
CA - Canada 12
EU - Europa 12
AU - Australia 9
ES - Italia 9
IN - India 9
BR - Brasile 7
CL - Cile 5
HK - Hong Kong 5
ID - Indonesia 5
TR - Turchia 5
AT - Austria 4
CH - Svizzera 4
GR - Grecia 4
CG - Congo 3
IL - Israele 3
NO - Norvegia 3
PH - Filippine 3
TW - Taiwan 3
UZ - Uzbekistan 3
AR - Argentina 2
DM - Dominica 2
MY - Malesia 2
NG - Nigeria 2
PK - Pakistan 2
SA - Arabia Saudita 2
VN - Vietnam 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
Totale 31.826
Città #
Woodbridge 8.139
Wilmington 7.430
Houston 7.180
Fairfield 1.081
Ann Arbor 685
Singapore 547
Chandler 465
Ashburn 458
Seattle 433
Cambridge 346
Jacksonville 333
Dublin 277
Medford 219
Dearborn 211
Beijing 129
New York 117
Santa Clara 116
Rome 109
Lawrence 103
Kraków 62
San Diego 59
Mülheim 51
Moscow 47
Menlo Park 44
Zhengzhou 42
Milan 30
Norwalk 29
Palo Alto 28
Munich 21
Redwood City 20
London 19
Brussels 16
Hangzhou 16
Brno 15
Council Bluffs 13
University Park 13
Verona 13
Falls Church 12
Hefei 12
Shanghai 12
Boardman 11
Saint Petersburg 11
Seoul 11
Del Norte 10
Toronto 10
Los Angeles 9
Mountain View 8
San Mateo 8
Ferrara 7
Guangzhou 7
Helsinki 7
Nanjing 7
Amsterdam 6
Center 6
Chicago 6
Detroit 6
Fuzhou 6
Kilburn 6
Madrid 6
Miami 6
Monmouth Junction 6
Sydney 6
Atlanta 5
Bologna 5
Jakarta 5
Monte Porzio Catone 5
Nürnberg 5
Phoenix 5
Brasília 4
Hebei 4
Jinan 4
Pirri 4
San Jose 4
Slough 4
Stafford 4
Tokyo 4
Agrigento 3
Auburn Hills 3
Bielefeld 3
Brazzaville 3
Changsha 3
Chester 3
Chongqing 3
Florence 3
Frankfurt am Main 3
Hounslow 3
Indiana 3
Nanchang 3
Nuremberg 3
Redmond 3
San Francisco 3
Taipei 3
Torre Annunziata 3
Vienna 3
Atripalda 2
Berlin 2
Brescia 2
Bristol 2
Chengdu 2
Cologne 2
Totale 29.246
Nome #
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 463
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 450
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 449
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 441
Transient global amnesia: linked to a systemic disorder of amino acid catabolism? 441
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. 438
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 435
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 432
Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients 427
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 426
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 424
Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry 422
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease 421
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 421
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 421
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain 417
"Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" 412
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 412
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients 409
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain. 408
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism? 407
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? 403
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 403
Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene 400
Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease 400
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex 400
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 400
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 399
Huntingtin distribution among striatal output neurons of normal rat brain 395
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 395
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 394
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 393
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 392
Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients 391
Reversal of LTP-Like cortical plasticity in Alzheimer's disease patients with tau-related faster clinical progression 389
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 387
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. 387
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? 387
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 382
Bromelain degrades Aβ1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients 382
Tissue plasminogen activator is required for corticostriatal long-term potentiation 381
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 381
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 381
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins 380
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 380
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 379
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 378
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study 378
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. 375
Plasmin system of Alzheimer's disease patients: CSF analysis 375
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 372
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra 367
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 366
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 364
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 358
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities 358
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 357
Detection of Aβ42 in the CSF of Alzheimer’s disease is influenced by handling temperature: indication of a reversible process of Aβ42 aggregation in vivo? 355
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 353
Frailty among Alzheimer's disease patients 349
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms 346
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? 345
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 343
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 340
Zinc distribution in various tissues, (brain, eye, skin, muscle and blood) of rat during hindlimb suspension 339
Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle 338
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients 336
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients. 333
Is dopamine involved in Alzheimer's disease? 330
The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients 327
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 326
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 314
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 295
Muscle regeneration in mdx mice: Resistance to repeated necrosis is compatible with myofiber maturity 288
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 261
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 256
Assessment of serum uric acid as risk factor for tauopathies 251
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 249
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 179
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 167
Alzheimer’s disease and the routine clinical use of CSF biomarkers 157
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 153
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 145
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 127
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 121
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 120
Insulin and the future treatment of Alzheimer’s disease 117
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 114
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 111
Ageing as a Trait de Union between diabetes and dementia for frailty 106
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 99
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State 98
Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease 94
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 67
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 65
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 57
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 55
Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients? 54
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 49
Hearing and cognitive impairment: a functional evaluation of associative brain areas in patients affected by Alzheimer's disease 48
Totale 31.762
Categoria #
all - tutte 67.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.891 0 0 0 0 0 902 747 750 713 700 513 566
2020/20215.337 718 658 582 700 569 531 614 514 107 124 179 41
2021/20221.175 55 159 88 37 32 114 55 90 71 80 74 320
2022/20231.289 145 111 45 131 100 299 110 58 114 16 109 51
2023/2024499 58 16 31 25 42 148 20 44 10 10 6 89
2024/20251.299 84 636 290 163 77 49 0 0 0 0 0 0
Totale 32.173